Rehabilitation treatment in patients with ankylosing spondylitis stabilized with tumor necrosis factor inhibitor therapy. A randomized controlled trial

S Masiero, L Bonaldo, M Pigatto, AL Nigro… - The journal of …, 2011 - jrheum.org
Objective. To assess the 2- (T1) and 6-month (T2) followup effects on pain, spine mobility,
physical function, and disability outcome of a rehabilitation intervention in patients with …

[HTML][HTML] Medium-/long-term effects of a specific exercise protocol combined with patient education on spine mobility, chronic fatigue, pain, aerobic fitness and level of …

E Giannotti, K Koutsikos, M Pigatto… - BioMed research …, 2014 - hindawi.com
… Of the 41 participants enrolled in this study, 20 patients (19 F, 1 M; mean age 52.8 years ±
10.69; mean BMI 24.4 ± 3.46) in the EG and 12 patients in the CG (11 F, 1 M; mean age 51.3 …

Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12 …

S Masiero, P Poli, L Bonaldo, M Pigatto… - Clinical …, 2014 - journals.sagepub.com
Objective: To assess the 12-month’s follow-up effects on pain, mobility, and physical function
outcomes of a supervised training and home-based rehabilitation for ankylosing spondylitis …

[HTML][HTML] Fasting and its impact on skin anatomy, physiology, and physiopathology: A comprehensive review of the literature

…, M Sellami, I Salem, R Conic, M Kimak, PDM Pigatto… - Nutrients, 2019 - mdpi.com
… Skin is the largest organ of the body, covering an impressive surface area of approximately
2 m 2 and accounting for about 20% of total adult body weight. Being situated at the interface …

[HTML][HTML] Psoriasis and respiratory comorbidities: the added value of fraction of exhaled nitric oxide as a new method to detect, evaluate, and monitor psoriatic systemic …

…, A Cristiano, R Conic, S Petrou, PDM Pigatto… - BioMed Research …, 2018 - hindawi.com
Psoriasis is a chronic inflammatory systemic disease characterized by a wide range of
comorbidities. Respiratory comorbidities are currently poorly characterized and with discordant …

[HTML][HTML] Nanotechnology meets atopic dermatitis: Current solutions, challenges and future prospects. Insights and implications from a systematic review of the …

G Damiani, R Eggenhöffner, PDM Pigatto… - Bioactive materials, 2019 - Elsevier
Atopic dermatitis is a chronic, relapsing, non-contiguous, exudative eczema/dermatitis, which
represents a complex, multi-factorial disorder, due to an impairment of the stratum corneum …

Induction of lipid peroxidation and decrease of antioxidant defenses in symptomatic and asymptomatic patients with X-linked adrenoleukodystrophy

…, A Sitta, AG Barschak, DM Coelho, M Pigatto… - International Journal of …, 2007 - Elsevier
Patients affected by X-linked adrenoleukodystrophy (X-ALD) present a progressive brain and
peripheral demyelination and adrenal cortex insufficiency, associated with accumulation of …

COVID‐19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): multi‐center, real‐life, telemedical, and observational prospective …

…, A Buja, NL Bragazzi, PDM Pigatto… - Dermatologic …, 2021 - Wiley Online Library
Masks are essential for COVID‐19 prevention, but recently they were suggested to modify
cutaneous facial microenvironment and trigger facial dermatoses. To evaluate mask‐related …

Sensitive analytical method to quantify clindamycin in plasma and microdialysate samples: Application in a preclinical pharmacokinetic study

NG Girondi, F Barreto, MC Pigatto… - Journal of Pharmaceutical …, 2018 - Elsevier
… Multiple reaction monitoring was used to detect the transitions m/z 425.3 > 377.3 for
clindamycin, and m/z 407 > 359 for lincomycin, both at 100-ms dwell time. The optimal ionization …

Nanoencapsulation improves relative bioavailability and antipsychotic effect of olanzapine in rats

FA Dimer, MC Pigatto, CA Boque… - Journal of …, 2015 - ingentaconnect.com
This study aimed to investigate the pharmacokinetics, tissue distribution and antipsychotic
activity of olanzapine administered as free drug (OLA-FREE) or loaded into lipid-core …